Checkmate Pharmaceuticals CMPI

$ 10.5 0.0%

Quarterly report 2022-Q1
added 12-23-2023

Checkmate Pharmaceuticals Balance Sheet 2011-2024 | CMPI

Annual Balance Sheet Checkmate Pharmaceuticals

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-12.1 M	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	9.38 M	7.88 M	5.63 M	-	-	-	-	-	-	-	-
Total Liabilities	9.38 M	7.88 M	5.63 M	3.32 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-201 M	-140 M	-97.4 M	-62.8 M	-	-	-	-	-	-	-
Total Assets	78.8 M	133 M	5.13 M	12.5 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	50.7 M	43.1 M	4.2 M	-	-	-	-	-	-	-	-
Book Value	69.5 M	125 M	-508 K	9.17 M	-	-	-	-	-	-	-
Total Shareholders Equity	69.5 M	125 M	-97.4 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Checkmate Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	11.9 M	9.38 M	7.81 M	6.7 M	7.31 M	7.88 M	8.86 M	6.98 M	7.88 M	5.63 M	5.63 M	5.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-217 M	-201 M	-188 M	-173 M	-154 M	-140 M	-129 M	-118 M	-140 M	-97.4 M	-97.4 M	-97.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	66.9 M	78.8 M	89.3 M	102 M	120 M	133 M	144 M	83.5 M	133 M	5.13 M	5.13 M	5.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	39.5 M	50.7 M	53.5 M	63.1 M	39.1 M	43.1 M	43.1 M	43.1 M	43.1 M	4.18 M	4.18 M	4.18 M	-	12.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	55 M	69.5 M	81.5 M	95 M	112 M	125 M	135 M	76.5 M	125 M	-508 K	-508 K	-508 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	55 M	69.5 M	81.5 M	95 M	112 M	-125 M	135 M	125 M	125 M	-97.4 M	-87.9 M	-97.4 M	-71.2 M	-62.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency